Baxter International Inc. develops and provides a wide range of healthcare products, primarily focused on therapies for kidney disease, intravenous therapies, and critical care solutions. Its revenue comes from multiple segments, including dialysis products (approximately 40%), intravenous therapies (30%), and surgical products (20%), with the remaining 10% from contracted services and connected care solutions. The company serves hospitals, dialysis centers, nursing homes, and home care patients, selling through direct sales and various distribution channels in about 100 countries. Factors supporting its endurance include a strong portfolio of essential healthcare products and a long-standing presence in the industry, while potential limitations may arise from regulatory challenges and competition in the healthcare sector.
—
Baxter International Inc. develops and provides a wide range of healthcare products, primarily focused on therapies for kidney disease, intravenous therapies, and critical care solutions. Its revenue comes from multiple segments, including dialysis products (approximately 40%), intravenous therapies (30%), and surgical products (20%), with the remaining 10% from contracted services and connected care solutions. The company serves hospitals, dialysis centers, nursing homes, and home care patients, selling through direct sales and various distribution channels in about 100 countries. Factors supporting its endurance include a strong portfolio of essential healthcare products and a long-standing presence in the industry, while potential limitations may arise from regulatory challenges and competition in the healthcare sector.
—
Daily adjusted close
Baxter International Inc. develops and provides a wide range of healthcare products, primarily focused on therapies for kidney disease, intravenous therapies, and critical care solutions. Its revenue comes from multiple segments, including dialysis products (approximately 40%), intravenous therapies (30%), and surgical products (20%), with the remaining 10% from contracted services and connected care solutions. The company serves hospitals, dialysis centers, nursing homes, and home care patients, selling through direct sales and various distribution channels in about 100 countries. Factors supporting its endurance include a strong portfolio of essential healthcare products and a long-standing presence in the industry, while potential limitations may arise from regulatory challenges and competition in the healthcare sector.